The treatment of gastroparesis in the age of the gastric pacemaker: A review

MedGenMed Medscape General Medicine

Volumn 5, Issue 4, 2003, Pages

  Buckles, Daniel C ^a   Forster, Jameson ^a   McCallum, Richard W ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BOTULINUM TOXIN A; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; METOCLOPRAMIDE; METRONIDAZOLE; OCTREOTIDE; PROKINETIC AGENT; SEROTONIN 4 RECEPTOR; SOMATOSTATIN DERIVATIVE; TEGASEROD;

BACTERIAL INFECTION; BACTERIAL OVERGROWTH; CLINICAL TRIAL; DIET THERAPY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG FATALITY; DRUG INDICATION; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; GYNECOMASTIA; HEART ARRHYTHMIA; HUMAN; LOW DRUG DOSE; MUSCLE CONTRACTILITY; NAUSEA AND VOMITING; NEUROTOXICITY; NONHUMAN; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; QUALITY OF LIFE; REVIEW; SIDE EFFECT; STOMACH FUNCTION; STOMACH MOTILITY; STOMACH MUSCLE; STOMACH PARESIS;

EID: 25144525553     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Hornbuckle K, Barnett JL. The diagnosis and work up of the patient with gastroparesis. J Clin Gastroenterol. 2000;30:117-124.
2. Kendall BJ, McCallum RW. Gastroparesis and the current use of prokinetic drugs. Gastroenterologist. 1993;1:107-114.
3. Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus, a review of symptoms, path physiology, and treatment. Dig Dis Sci. 1999;44:1061-1075.
4. Hinder RA, Kelly KA. Human gastric pacesetter potential: site of origin, spread, and response to gastric transection and proximal gastric agronomy. Am J Surg. 1978;133:29-33.
5. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological abuse profiles, treatment, and long-term follow-up of patients with gastro paresis. Dig Dis Sci. 1998;43:2398-2404.
6. Horowitz M, Edelbroek M, Fraser, et al. Disordered gastric motor function in diabetes mellitus: recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol 1991:26:673-684.
7. Abell TL, Camilleri M, Hench VS, et al. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol. 1991;3:163-167.
8. Rothstein RD, Alavi A, Reynolds JC. Electrogastrography in patients with gastroparesis and effect of long-term cisapride. Dig Dis Sci. 1993;38:1518-1524.
9. Malagelada JR, Rees WDW, Mazzotta LJ, et al. Gastric motor abnormalities in diabetic and post-agronomy gastro paresis: effect of metoclopramide and bethanechol. Gastroenterology. 1980;78:286-293.
10. Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology. 1995;108:727-736.
11. Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycemia slows gastric emptying in Type I (insulin dependant) diabetes mellitus. Diabetologia. 1990;33:675-680.
12. Walsh JW, Hasler WL, Nugent CE, et al. Progesterone and estrogen are potential mediators of gastric slow wave dysrhythmias in nausea of pregnancy. Am J Physiol Gastrointest Liver Physiol. 1996;270:G506-G514.
13. Nilsson PH. Diabetic gastroparesis: a review. J Diabetes Complications. 1996;10:113-122.
14. Forster J, Sarosiek I, Delcore R, et al. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surgery. 2001;182:676-681.
15. Ricci DA, Saltzman MB, McCallum RW, et al. Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol. 1985;7:25-32.
16. Albibi R, McCallum RW. Metoclopramide: pharmacology and clinical application. Ann Intern Med. 1983;98:86-95.
17. McCallum RW, Valenzuela G, Spyker D, et al. Subcutaneous metoclopramide in the treatment of symptomatic gastro paresis: clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther. 1991;258:136-142.
18. Dumitrascu DL, Weinbeck M. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis. Am J Gastroenterol. 2000;95:316-317.
19. Soykan I, Sarosiek I, McCallum R. The effect of chronic oral domperidone therapy on the gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol. 1997;92:976-980.
20. Silvers D, Kipnes M, Broadstone V, et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. Clin Ther 1998;20:438-453.
21. Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol. 1993;88:203-207.
22. Camilleri M, Malagelada JR, Abell TR, et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology. 1989;96:704-712.
23. Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology. 2000;118:463-468.
24. Tougas G, Chen Y, Luo D, et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms. Gastroenterology. 2003;124:A-54.
25. Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol. 2002;97:1653-1660.
26. Lacy BE, Zayat EN, Crowell MD, et al. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol. 2002;97:1548-1552.
27. Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc. 2002;55:920-923.
28. Abell TR, McCallum RW, Hocking M, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology. 2003;125:421-428.
29. McElhinney C, Sarosiek I, Lin Z, et al. Comparison of hospitalizations, medications, and quality of life in patients receiving gastric electrical stimulation therapy (GES) for severe gastroparesis. Gastroenterology. 2002;122:A-82.
30. McCallum RW, George SJ. Gastroparesis. Clinical Perspectives in Gastroenterology. May/June 2001:147-154.
31. Sarosiek I, McCallum RW, Roeser K, et al. Gastric electrical stimulation for medically refractory diabetic gastroparesis: a single center experience. Program and abstracts of the American Diabetes Association 63rd Scientific Sessions; June 13-17, 2003; New Orleans, Louisiana.
32. Forster J, Damjanov I, Lin Z, et al. Absence of interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. Am J Gastrointest Surg. 2003. In press.
33. Wetzel P, McCallum RW, Sarosiek I, et al. Gastric electrical stimulation is effective in alleviating nausea and vomiting and improving quality of life in post-surgical gastroparesis. Gastroenterology. 2003;124:A-575.
34. Tougas G, Eaker EY, McCallum RW, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456-1462.
35. Schade RR, Dugas MC, Lhotsky DM, et al. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci. 1985;30:10-15.
36. Horowitz M, Maddox A, Harding PE, et al. Effect of cisapride on gastric and esophageal emptying in insulin-dependant diabetes mellitus. Gastroenterology. 1997;92:1899-1907.
37. De Block CE, De Leeuw IH, Pelckmans PA, et al. Delayed gastric emptying and gastric autoimmunity in type I diabetes. Diabetes Care. 2002;25:912-917
38. McCallum RW, Lin Z, Olyaee M, et al. High-frequency electrical stimulation of the stomach for the treatment of gastroparesis. Neurogastroenterol Motil 2000;12:488.
39. Tougas G, Huizinga JD. Gastric pacing as a treatment for intractable gastroparesis: shocking news? Gastroenterology. 1998;114:598-601.
40. Lin Z, Forster J, Sarosiek, et al. Effect of high-frequency electrical stimulation of the stomach on gastric myoelectrical activity in gastroparetic patients. Program and abstracts of the Second Joint EMBS/BMES Conference; October 23-26, 2002; Houston, Texas. Pages 1793-1794.
41. Al-Juburi A, Familoni B, Rashed H, et al. Intra-operative frequency to amplitude ratio (FAR) and the outcome of gastric stimulation: a far-out idea? Neurogastroenterol Motil. 2002;14:433.
42. Tack J, Coulie B, Van Cutsem, et al. The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis. Gastroenterology 1999;116:G4733.
43. Al-Juburi A, Rashed H, Juo J, et al. Andrenergic and cholinergic measures help predict response to gastric electrical stimulation. Neurogastroenterol Motil. 2002;14:432.
44. Al-Juburi A, Luo J, Rashed H, et al. Gastric electrical stimulation is associated with increased pancreatic synthetic function when compared to normals and medical controls. Gastroenterology. 2001;120:A-647.
45. Mintchev MP, Bowes KL. Computer model of gastric electrical stimulation. Ann Biomed Eng 1997;25:726-730.
46. Mintchev MP, Bowes KL. Production of propagated antral contractions by electrical stimulation. Dig Dis Sci. 1996;41:1890.
47. Mintchev MP, Sanmiguel CP, Otto SG, et al. Microprocessor-controlled movement of liquid gastric content using sequential neural electrical stimulation. Gut. 1998;43:607-611.
48. McCallum RW, Chen JDZ, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology. 1998;114:456-461.